LRP5 gene polymorphisms and idiopathic osteoporosis in men.

[1]  J. Bilezikian,et al.  Osteoporosis in men. , 2007, Endocrinology and metabolism clinics of North America.

[2]  A. Uitterlinden,et al.  Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. , 2004, American journal of human genetics.

[3]  A. Uitterlinden,et al.  Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. , 2004, JAMA.

[4]  A. Uitterlinden,et al.  Influence of LRP5 Polymorphisms on Normal Variation in BMD , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  J. Kaufman,et al.  Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. , 2004, The Journal of clinical endocrinology and metabolism.

[6]  E. Dermitzakis,et al.  Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. , 2004, American journal of human genetics.

[7]  L. Cardon,et al.  Site and Gender Specificity of Inheritance of Bone Mineral Density , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  S. Khosla,et al.  The role of estrogens in men and androgens in women. , 2003, Endocrinology and metabolism clinics of North America.

[10]  Jens Bollerslev,et al.  Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. , 2003, American journal of human genetics.

[11]  D. Bacquer,et al.  Deficient Acquisition of Bone During Maturation Underlies Idiopathic Osteoporosis in Men: Evidence From a Three‐Generation Family Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  M. Bouxsein,et al.  Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization* , 2002, The Journal of Biological Chemistry.

[13]  T. Foroud,et al.  Genetics of osteoporosis. , 2002, Endocrine reviews.

[14]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[15]  C. Baudoin,et al.  Genetic and environmental factors affect bone density variances of families of men and women with osteoporosis. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[17]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[18]  J. Eisman,et al.  Genetics of Fracture: Challenges and Opportunities , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  C. Baudoin,et al.  Bone Mass in Middle‐Aged Osteoporotic Men and Their Relatives: Familial Effect , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  J. Bilezikian,et al.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.

[21]  J. Bilezikian,et al.  Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.

[22]  D Dempster,et al.  Insulin-like growth factor-I in men with idiopathic osteoporosis. , 1997, The Journal of clinical endocrinology and metabolism.

[23]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[24]  P. McCullagh,et al.  Generalized Linear Models , 1992 .

[25]  P. Marie,et al.  Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. , 1991, The Journal of clinical investigation.

[26]  P. McCullagh,et al.  Generalized Linear Models, 2nd Edn. , 1990 .

[27]  R. Tibshirani,et al.  Generalized Additive Models , 1986 .

[28]  P. McCullagh,et al.  Generalized Linear Models , 1984 .

[29]  Zhaohui S. Qin,et al.  Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[30]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[31]  M. Fishbein.  False positive rate of screening mammography. , 1998, The New England journal of medicine.

[32]  A. Lindahl,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Reduced Serum Levels of the Growth Hormone- Dependent Insulin-Like Growth Factor Binding Protein and a Negative Bone Balance at the Level of Indiv , 2022 .